Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Top Stories

Top Stories

Group By Ticker
Sort By
Newest | Oldest
Read More
2 minute read
  • Analyst Ratings
  • News
  • Price Target
  • Reiteration
  • Tech
  • Top Stories
  • Trading Ideas

Snowflake’s GenAI Initiatives Drive Investor Interest: Analyst Sees Strong Revenue Growth Ahead

By Anusuya Lahiri
May 29, 3:40 PM
Snowflake Inc (NYSE: SNOW) reiterated as Buy with $210 price target by Needham analyst Mike Cikos due to GenAI initiatives and new CEO's direction.

CLOU

Read More
2 minute read
  • Analyst Color
  • Analyst Ratings
  • Biotech
  • Downgrades
  • General
  • Health Care
  • Movers
  • News
  • Price Target
  • Top Stories
  • Trading Ideas

Ikena Oncology Discontinues IK-930 Program And Cuts Workforce, Analyst Calls It ‘Disappointing’

By Vandana Singh
May 29, 3:33 PM
Ikena Oncology halts its IK-930 program after reviewing clinical data and resources, focusing on the novel MEK-RAF molecular glue, IK-595.

IKNA

Read More
2 minute read
  • General
  • Top Stories

Taylor Swift’s Favorite Sneaker Brand Is Going Public: Golden Goose Boasts $3.3B Valuation

By Aaron Bry
May 29, 3:32 PM
Golden Goose compared to Crocs (valued at around $10 billion) and Skechers (valued at around $10 billion). 

BABA

Read More
3 minute read
  • Cryptocurrency
  • News
  • Top Stories

EXCLUSIVE: Can BRETT Become The Shiba Inu Of The Base Blockchain?

By Murtuza Merchant
May 29, 3:20 PM
BRETT (CRYPTO: BRETT), a meme coin inspired by the character of the same name from the popular comic series “Boys Club,” is aiming to becom

$DOGE

Read More
1 minute read
  • Biotech
  • FDA
  • General
  • Health Care
  • Large Cap
  • News
  • Top Stories

FDA Conditionally Approves Eli Lilly’s Thyroid Cancer Drug For Pediatric Patients With Certain Mutations

By Vandana Singh
May 29, 3:02 PM
Accelerated FDA approval for Eli Lilly's selpercatinib (Retevmo) in pediatric patients aged 2+ with advanced/metastatic thyroid cancer & solid tumors carrying RET mutations or fusions.

LLY

Read More
2 minute read
  • Analyst Color
  • Analyst Ratings
  • Commodities
  • ETFs
  • Long Ideas
  • Markets
  • Sector ETFs
  • Specialty ETFs
  • Top Stories
  • Trading Ideas

Hybrid Vehicle Adoption: Key Implications For Lithium, Rare Earths, Copper And Aluminum Investors

By Surbhi Jain
May 29, 2:47 PM
Hybrid electric vehicle adoption is reshaping demand for lithium, rare earths, copper, and aluminum. Investors should monitor ETFs like LIT, BATT, and CPER for potential opportunities and challenges.

BATT

Read More
2 minute read
  • Analyst Color
  • Analyst Ratings
  • Biotech
  • General
  • Health Care
  • Movers
  • News
  • Top Stories
  • Trading Ideas

Biohaven Stock Stumbles As Protein-Degrading Drug Falls Short Of Expectations In Early-Stage Study

By Vandana Singh
May 29, 2:47 PM
Biohaven shares drop as interim data from the Phase 1 study of BHV-1300 fell short of investor expectations.

ARGX

Read More
2 minute read
  • Economics
  • Federal Reserve
  • General
  • Government
  • Macro Economic Events
  • News
  • Top Stories

Former Goldman Sachs Exec Beth Hammack Chosen As Next President Of Cleveland Fed

By Vandana Singh
May 29, 2:38 PM
Meet Beth Hammack, the incoming President & CEO of the Federal Reserve Bank of Cleveland. With 30+ years in finance, including roles at Goldman Sachs.

GS

Read More
3 minute read
  • Analyst Color
  • Analyst Ratings
  • Previews
  • Price Target
  • Reiteration
  • Top Stories
  • Trading Ideas

Costco Q3 Earnings Preview: Analyst Estimates, Foot Traffic Data, Membership Fee Increase Eyed By Investors

By Chris Katje
May 29, 2:33 PM
Costco's Q3 could see strong customer growth predicted by foot traffic. The quarter could also show market share gains from other retailers.

COST

Read More
2 minute read
  • Emerging Market ETFs
  • ETFs
  • Specialty ETFs
  • Tech
  • Top Stories

Artificial Intelligence ETFs: Have They Beaten The Market In 2024?

By Hayden Buckfire
May 29, 2:22 PM
AI ETFs like BOTZ, AIQ, and ROBO have performed well in 2024 but couldn't beat the S&P 500, driven by tech giants like NVIDIA and Microsoft.

ABBNY

Posts pagination

Previous 1 … 82 83 84 … 1,424 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service